These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28244976)

  • 21. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
    Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
    Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.
    Genestreti G; Moretti A; Piciucchi S; Tiseo M; Bersanelli M; Scarlattei M; Scarpi E; Dubini A; Matteucci F; Sanna S
    Technol Cancer Res Treat; 2012 Apr; 11(2):163-7. PubMed ID: 22335410
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    García Vicente AM; Talavera Rubio MP; Dominguez Ferreras E; Calle Primo C; Amo-Salas M; Tello Galán MJ; Jiménez Londoño GA; Jiménez Aragón F; Hernández Ruiz B; Soriano Castrejón Á
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(3):151-155. PubMed ID: 29107751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Focal Peritoneal Mesothelioma Demonstrated on FDG PET/CT.
    Xiao J; Yin H; Cheng D; Shi H; Xiu Y
    Clin Nucl Med; 2019 Nov; 44(11):886-888. PubMed ID: 31107757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
    Dubreuil J; Giammarile F; Rousset P; Rubello D; Colletti PM; Glehen O; Skanjeti A
    Nucl Med Commun; 2017 Jan; 38(1):1-9. PubMed ID: 27820721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?
    Panagiotidis E; Datseris IE; Rondogianni P; Vlontzou E; Skilakaki M; Exarhos D; Bamias A
    Nucl Med Commun; 2014 Jun; 35(6):598-605. PubMed ID: 24681767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mesothelioma staging with ¹⁸F-FDG PET/CT. A case report with simultaneous pleural and peritoneal infiltration].
    Moreno C; Soler M; Mourelo S; Moragas M; Riera E; Garcia JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):141-2. PubMed ID: 25049160
    [No Abstract]   [Full Text] [Related]  

  • 29. High prognostic value of 18F-FDG PET for metastatic gastroenteropancreatic neuroendocrine tumors: a long-term evaluation.
    Bahri H; Laurence L; Edeline J; Leghzali H; Devillers A; Raoul JL; Cuggia M; Mesbah H; Clement B; Boucher E; Garin E
    J Nucl Med; 2014 Nov; 55(11):1786-90. PubMed ID: 25286923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of 18F-FDG PET/CT in the staging of pediatric peritoneal mesothelioma.
    Abikhzer G; Gourevich K; Arkovitz M; Postovsky S; Keidar Z
    Clin Nucl Med; 2013 Aug; 38(8):e331-2. PubMed ID: 23478845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels.
    Ozkan E; Soydal C; Araz M; Kir KM; Ibis E
    Nucl Med Commun; 2012 Apr; 33(4):395-402. PubMed ID: 22367859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters.
    Nowak AK; Francis RJ; Phillips MJ; Millward MJ; van der Schaaf AA; Boucek J; Musk AW; McCoy MJ; Segal A; Robins P; Byrne MJ
    Clin Cancer Res; 2010 Apr; 16(8):2409-17. PubMed ID: 20371686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma.
    Cao Q; Lu M; Heath J; Hausner PF; Alexander HR; Dilsizian V; Chen W
    Clin Nucl Med; 2012 May; 37(5):492-4. PubMed ID: 22475902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT,
    Yoo J; Lee JM; Joo I; Lee DH; Yoon JH; Yu MH; Jang JY; Lee SH
    Cancer Imaging; 2023 May; 23(1):49. PubMed ID: 37217958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histology of the pleural rind at [
    Soltermann A; Opitz I; Burger IA
    Pathol Res Pract; 2021 Dec; 228():153660. PubMed ID: 34749212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum.
    Wang SB; Ji YH; Wu HB; Wang QS; Zhou WL; Lv L; Shou T; Hu J
    Medicine (Baltimore); 2017 Jan; 96(2):e5867. PubMed ID: 28079823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma.
    Tan C; Barrington S; Rankin S; Landau D; Pilling J; Spicer J; Cane P; Lang-Lazdunski L
    J Thorac Oncol; 2010 Mar; 5(3):385-8. PubMed ID: 20087231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Case of Localized Malignant Peritoneal Mesothelioma With Lung Cancer Detected by 18F-FDG PET/CT.
    Kobayashi Shimizu S; Okamura T; Koyama K; Seura H; Nishida N
    Clin Nucl Med; 2020 Oct; 45(10):795-797. PubMed ID: 32558713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma.
    Lee ST; Ghanem M; Herbertson RA; Berlangieri SU; Byrne AJ; Tabone K; Mitchell P; Knight SR; Feigen M; Scott AM
    Mol Imaging Biol; 2009; 11(6):473-9. PubMed ID: 19330385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation.
    Guay C; Lépine M; Verreault J; Bénard F
    J Nucl Med; 2003 Aug; 44(8):1225-31. PubMed ID: 12902411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.